18.91
Kenvue Inc stock is traded at $18.91, with a volume of 27.63M.
It is up +1.29% in the last 24 hours and up +6.06% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$18.67
Open:
$18.74
24h Volume:
27.63M
Relative Volume:
1.27
Market Cap:
$36.32B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
22.42
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
+6.84%
1M Performance:
+6.06%
6M Performance:
+8.30%
1Y Performance:
+34.02%
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, EL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KVUE
Kenvue Inc
|
18.91 | 36.32B | 15.29B | 1.62B | 1.82B | 0.8433 |
|
PG
Procter Gamble Co
|
159.35 | 370.12B | 86.72B | 16.69B | 15.03B | 6.8375 |
|
UL
Unilever Plc Adr
|
66.16 | 142.48B | 56.67B | 6.96B | 7.39B | 3.1265 |
|
CL
Colgate Palmolive Co
|
94.11 | 75.02B | 20.80B | 2.22B | 3.77B | 2.5772 |
|
EL
Estee Lauder Cos Inc
|
104.54 | 37.88B | 14.85B | -248.00M | 1.29B | -0.6966 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Implements Third Supplemental Indenture, Easing Covenants for Kimberly-Clark's $7 Billion Note Exchange - TradingView
Kimberly-Clark receives consents for Kenvue note amendments By Investing.com - Investing.com Canada
Kimberly-Clark Receives Requisite Consents For Amendments To All Kenvue Notes - TradingView
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers - PR Newswire
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers - TradingView
Form 4 Kenvue Inc For: 11 October By Investing.com - Investing.com South Africa
2 Dividend Stocks Worth Holding Forever (Including 1 Dividend King) - The Motley Fool
PIMCO Global Core Asset Allocation Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. Research & Ratings | KVUE - Barron's
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Market Concentration Is Spooking Wall Street—I’m Buying Kenvue - Yahoo Finance
Kimberly-Clark’s (KMB) Kenvue (KVUE) Deal Has Jim Cramer Looking Years Ahead - Yahoo Finance
Form 4 Kenvue Inc For: 6 October By Investing.com - Investing.com Nigeria
24,732 shares go to Kenvue (KVUE) executive Caroline Tillett; 8,471 are withheld for taxes. - Stock Titan
A performance award vested at 100%; Kenvue (KVUE) executive received 36,597 shares. - Stock Titan
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kimberly-Clark announces leadership changes ahead of Kenvue acquisition - Tissue Online North America
NWL or KVUE: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Kenvue Inc. (NYSE:KVUE) Stock Has Consensus Target Price of $19.00 - MarketBeat
An award vests into 66K shares for Kenvue (KVUE)’s Michael Wondrasch; 21,031 shares cover taxes. - Stock Titan
Kenvue Inc. stock rises Monday, outperforms market - MarketWatch
VY(R) American Century Small-Mid Cap Value Portfolio's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. Advanced Charts | KVUE - Barron's
Kenvue Inc. Financials | KVUE - Barron's
Kenvue (KVUE), Why Is It Drawing Fresh Attention Now? - Yahoo Finance
Kenvue Inc. stock falls Thursday, underperforms market - MarketWatch
Montgomery Township Weighs Farmland Preservation, Public Health, and Kenvue Site Redevelopment - themontynews.org
Keurig taps Kimberly-Clark exec to lead coffee spinoff - The Business Journals
Kimberly-Clark Slides as Investors Weigh Leadership Change and Kenvue Deal Execution - Quiver Quantitative
Kimberly-Clark Reshapes Leadership Ahead of Kenvue Acquisition - citybiz
Kimberly-Clark announces executive changes ahead of Kenvue deal - Investing.com
Kimberly-Clark President, COO Russ Torres to Step Down Ahead of Kenvue Acquisition - marketscreener.com
Kimberly-Clark's COO will leave for an outside CEO role - Stock Titan
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team - PR Newswire
Worldwide oral disease cases reach 3.73 billion. Listerine is launching a prevention campaign. - Stock Titan
Kenvue brands present skin and hair research at Vienna congress - Investing.com
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair - Kenvue Investor Relations
Form 4 Kenvue Inc For: 29 September By Investing.com - Investing.com Nigeria
Deferred director pay adds 1,300 stock units for Jeffrey C. Smith at Kenvue (KVUE). - Stock Titan
1,461 shares withheld for taxes on a Kenvue (KVUE) executive’s stock awards - Stock Titan
Kenvue (KVUE) director Richard E. Allison Jr. receives deferred pay in shares - Stock Titan
ETFs Investing in Kenvue, Inc. Stocks - TradingView
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes - PR Newswire
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue stock slips 1.06 percent ahead of the open - AD HOC NEWS
Andra AP fonden Acquires Shares of 210,900 Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal - Reuters
kimberly clark offers eu remedies for 40 billion kenvue deal - grafa.com
Nykredit A S Acquires Shares of 235,332 Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kenvue Inc Stock (KVUE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Howlett Heather | Officer |
Jun 10 '26 |
Proposed Sale |
18.11 |
3,700 |
66,988 |
0 |
| Howlett Heather | CFO & CAO |
Jun 10 '26 |
Sale |
18.11 |
3,700 |
66,988 |
29,288 |
| Orlando Matthew | General Counsel |
May 08 '26 |
Sale |
17.66 |
38,491 |
679,691 |
0 |
| Orlando Matthew | Officer |
May 08 '26 |
Proposed Sale |
17.66 |
38,492 |
679,691 |
0 |
| Curado Gomes de Lemos Leonardo | Group President LATAM |
May 01 '26 |
Option Exercise |
0.00 |
24,248 |
0 |
24,248 |
| Alvarado Luani | Chief People Officer |
Mar 10 '26 |
Option Exercise |
0.00 |
4,222 |
0 |
62,797 |
| Stevens Meredith | Chief Operations Officer |
Mar 10 '26 |
Option Exercise |
0.00 |
5,170 |
0 |
94,877 |
| Lawson Carlton | Group President EMEA & LA |
Mar 10 '26 |
Option Exercise |
0.00 |
6,158 |
0 |
111,415 |
| Lawson Carlton | Group President EMEA & LA |
Mar 05 '26 |
Option Exercise |
0.00 |
7,736 |
0 |
105,257 |
| Alvarado Luani | Chief People Officer |
Mar 05 '26 |
Option Exercise |
0.00 |
4,289 |
0 |
61,365 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):